Zydus Wellness Designated Person Acquires 1,500 Equity Shares Worth ₹6.04 Lakh
Zydus Wellness Limited disclosed that designated person Rinesh Gajjar acquired 1,500 equity shares worth ₹6,04,443.15 from the open market between March 12-13, 2026. The transaction was executed on NSE and disclosed on March 16, 2026, under SEBI insider trading regulations. Post-acquisition, Gajjar's shareholding remains at 0.00% of the company's total share capital.

*this image is generated using AI for illustrative purposes only.
Zydus Wellness Limited has made a regulatory disclosure regarding the acquisition of equity shares by one of its designated persons under the SEBI Prohibition of Insider Trading Regulations, 2015. The transaction involves Mr. Rinesh Gajjar, who purchased shares from the open market during March 2026.
Transaction Details
The share acquisition by the designated person involved specific parameters that have been disclosed in compliance with regulatory requirements. Mr. Rinesh Gajjar acquired the shares through open market transactions executed on the National Stock Exchange.
| Parameter | Details |
|---|---|
| Acquirer | Rinesh Gajjar (Designated Person) |
| Number of Shares | 1,500 equity shares |
| Share Face Value | ₹2 per share |
| Transaction Value | ₹6,04,443.15 |
| Acquisition Period | March 12, 2026 to March 13, 2026 |
| Exchange | National Stock Exchange (NSE) |
| Disclosure Date | March 16, 2026 |
Shareholding Position
The acquisition represents a change in the designated person's shareholding position in Zydus Wellness Limited. Prior to this transaction, Mr. Gajjar held no equity shares in the company, representing 0.00% shareholding.
| Shareholding Status | Number of Shares | Percentage |
|---|---|---|
| Pre-acquisition | 0 | 0.00% |
| Post-acquisition | 1,500 | 0.00% |
Regulatory Compliance
The disclosure has been made in prescribed Form B under Regulation 7(2) of SEBI Prohibition of Insider Trading Regulations, 2015. The company secretary and compliance officer, Nandish P. Joshi, submitted the disclosure to both BSE Limited and National Stock Exchange of India Limited on March 18, 2026. The designated person is based at Zydus Corporate Park in Ahmedabad, Gujarat, and the transaction was completed through open market purchases on NSE. No derivative trading was involved in this transaction, as confirmed in the regulatory filing.

































